Nano Dimension to Acquire Infinite Epigenetics in $890M Deal, Pivoting to AI-Powered Health
NNDM sits 17% above its 52-week low of $1.31.
Summary
Nano Dimension is pivoting its entire business by proposing to acquire Infinite Epigenetics for $890 million, shifting from digital manufacturing to AI-powered preventive health and diagnostics. This non-binding term sheet outlines a transformational merger that will see Nano's capital deployed into a new high-growth sector, with existing shareholders retaining a minority stake and receiving a premium on cash.
Key Events · M&A and Partnerships · NNDM
-
Strategic Business Combination Announced
Nano Dimension signed a non-binding term sheet to acquire Infinite Epigenetics, an AI-powered preventive health and diagnostics company, for an implied valuation of $890 million.
-
Major Strategic Pivot
This transaction represents a complete shift from Nano Dimension's historical digital manufacturing business into the high-growth healthcare AI sector, following a multi-month strategic review.
-
Shareholder Value Protection
Existing Nano Dimension shareholders are expected to retain a meaningful minority ownership, receive a 20% premium on Nano's estimated net cash, and get Contingent Value Rights (CVRs) for proceeds from legacy asset dispositions.
-
Strong Combined Financial Position
The combined company is projected to have over $400 million in cash at closing, providing significant capital for growth and operational runway.
Analysis · NNDM · Manufacturing
Nano Dimension has entered a non-binding term sheet to acquire Infinite Epigenetics for $890 million, marking a complete strategic pivot from digital manufacturing to AI-powered preventive health and diagnostics. This transformational deal, which values Infinite at nearly three times Nano's current market capitalization, aims to deploy Nano's capital base into a high-growth sector. Existing Nano shareholders are expected to retain a meaningful minority stake and receive a 20% premium on Nano's estimated net cash, plus contingent value rights for legacy assets. The combined entity is projected to have over $400 million in cash, providing substantial financial flexibility. This follows Nano's previously announced strategic review and ongoing activist investor engagement, with a definitive agreement targeted before the July 31st Extraordinary General Meeting.
At the time of this filing, NNDM was trading at $1.53 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $309.9M. The 52-week trading range was $1.31 to $2.32. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.